Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Longboard Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 19 | 18 | −1 |
| Shares | 7.26M | 7.27M | +13.1K (+0.2%) |
| Value | $27.0M | $23.3M | −$3.67M (−13.6%) |
New holders (2)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bourgeon Capital Management LLC | 3,500 | $11.4K | 0.00% |
| UBS Group AG | 971 | $3.17K | 0.00% |
Sold out (3)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| OrbiMed Advisors LLC | 113,500 | $422.0K |
| Citigroup Inc | 112,605 | $419.0K |
| Royal Bank of Canada | 15 | $0 |